Featured
May 11, 2020
Peptides that can be taken as a pill
Peptides represent a billion-dollar market in the pharmaceutical industry, but they can generally only be taken as injections to avoid degradation by stomach enzymes
March 24, 2020
Insulin Gains New Pathway to Increased Competition
March 17, 2020
Could Blockchain Ensure Integrity of Clinical Trial Data?
February 25, 2020
Essential oil components can be tested as drug candidates
Latest Articles
April 1, 2019
New gene therapy to treat rare inherited blood condition
EMA has recommended granting a marketing authorisation in the European Union for a genetically modified product for beta-thalassaemia,…
September 25, 2018
FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
he U.S. Food and Drug Administration today announced that it has awarded 12 new clinical trial…
August 8, 2018
FDA approves treatment for two rare types of non-Hodgkin lymphoma
The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the…
July 31, 2018
FDA approves first treatment for rare adrenal tumors
The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use…
July 30, 2018
New medicine for hereditary rare disease
June 1, 2018
First monoclonal antibody therapy for prevention of migraine
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorisation for…
June 1, 2018
New medicine for hereditary rare disease
The European Medicines Agency’s has recommended granting a marketing authorisation in the European Union (EU) for Tegsedi (inotersen),…